‘That’s an absurd statement’: Sanders loses cool at RFK Jr. over his remark on prescription drugs

Key Concepts

• Prescription Drug Pricing: The disparity between U.S. drug costs and international benchmarks (OECD).
• Ultra-Processed Food Labeling: Regulatory efforts to define and label food products to combat obesity and chronic disease.
• Public Health Infrastructure: The role of the CDC in monitoring infectious and rare diseases (Rabies, Prion diseases).
• Budgetary Constraints: The tension between federal debt reduction ($39 trillion) and the maintenance of critical public health services.
• Direct-to-Consumer (DTC) Advertising: The debate over banning prescription drug TV advertisements.

1. Prescription Drug Pricing and Policy

• The Pricing Debate: Senator Bernie Sanders challenged Secretary Kennedy on the claim that the U.S. pays the lowest prices for prescription drugs. Sanders cited the RAND Corporation, noting that the U.S. pays nearly three times as much for drugs as 33 other OECD countries.
• Specific Examples: Sanders highlighted the cancer drug Opdivo, which costs $260,000 in the U.S. compared to $56,000 in Japan.
• Legislative Goals: Sanders proposed an amendment to the budget process to codify that the U.S. should not pay higher prices than other nations. Secretary Kennedy expressed theoretical support for this alignment with President Trump’s stated goals.
• DTC Advertising: Both parties agreed in principle that prescription drug TV ads should be banned. Kennedy noted that while a total ban faces constitutional hurdles, the administration is currently regulating these ads through disciplinary letters.

2. Public Health and Food Regulation

• Food Labeling: Secretary Kennedy acknowledged that ultra-processed foods contribute to 80% of Medicaid and Medicare expenditures. He stated that HHS has developed a federal definition for "ultra-processed food" and is currently navigating the interagency review process (involving the USDA, Department of Commerce, and OMB) before finalizing new labeling requirements.
• Medicare Expansion: Senator Sanders introduced an amendment to expand Medicare coverage to include dental, hearing, and vision services, citing the financial inability of many seniors to afford these basic needs.

3. CDC Infrastructure and Infectious Disease Oversight

• Rabies Division: Senator Warnock highlighted that the CDC’s 24/7 emergency response line for rabies—a disease that is 100% fatal if untreated—has been reduced to a single staff member under the current administration.
• Prion Diseases: Warnock questioned the proposed elimination of the CDC’s Prion and Public Health Office. Prion diseases (such as Mad Cow disease) are rare, fatal, and cause rapid neurodegeneration. Warnock argued that this office is vital for rural communities and hunters (over 600,000 in Georgia).
• Budgetary Justification vs. Public Safety: Secretary Kennedy defended the cuts by citing a 12% agency-wide reduction mandate necessitated by the $39 trillion national debt. He argued that given the rarity of these diseases, current staffing levels are sufficient.

4. Key Arguments and Perspectives

• Senator Sanders: Argued that the administration’s rhetoric regarding "lowest drug prices" is factually incorrect and that the government must take aggressive legislative action to lower costs and improve public health transparency.
• Senator Warnock: Argued that the administration is "gutting" the CDC’s core mission under the guise of fiscal responsibility, effectively endangering the public by removing specialized expertise. He concluded by calling for Secretary Kennedy’s resignation, stating he is "in over his head."
• Secretary Kennedy: Maintained that the administration is working to restore the CDC’s focus on infectious diseases while simultaneously managing severe budgetary constraints. He emphasized that the administration is prioritizing the most common drugs for price reductions.

5. Synthesis and Conclusion

The hearing underscored a deep ideological and operational divide. While there is bipartisan interest in lowering drug prices and improving food labeling, the administration’s approach to public health—characterized by significant budget cuts to the CDC—has drawn sharp criticism from legislators. The debate highlights a fundamental conflict: the administration’s focus on fiscal austerity and debt reduction versus the legislative concern that such cuts are dismantling the essential, invisible infrastructure that protects the American public from rare but catastrophic health threats.